Hostname: page-component-89b8bd64d-4ws75 Total loading time: 0 Render date: 2026-05-06T11:12:32.446Z Has data issue: false hasContentIssue false

Zinc toxicity induces intestinal cell death via inhibiting NAD+ synthesis in mice and IPEC-J2 cells

Published online by Cambridge University Press:  18 July 2025

Lingjun Chen
Affiliation:
Key Laboratory of Animal Nutrition & Feed Sciences of Zhejiang Province, College of Animal Science, Zhejiang University, Hangzhou, China
Feifei Huang
Affiliation:
Key Laboratory of Animal Nutrition & Feed Sciences of Zhejiang Province, College of Animal Science, Zhejiang University, Hangzhou, China
Leilei Zhu
Affiliation:
Key Laboratory of Animal Nutrition & Feed Sciences of Zhejiang Province, College of Animal Science, Zhejiang University, Hangzhou, China
Xin Tian
Affiliation:
Key Laboratory of Animal Nutrition & Feed Sciences of Zhejiang Province, College of Animal Science, Zhejiang University, Hangzhou, China
Mohan Zhou
Affiliation:
Key Laboratory of Animal Nutrition & Feed Sciences of Zhejiang Province, College of Animal Science, Zhejiang University, Hangzhou, China
Jie Feng*
Affiliation:
Key Laboratory of Animal Nutrition & Feed Sciences of Zhejiang Province, College of Animal Science, Zhejiang University, Hangzhou, China
*
Corresponding author: Jie Feng; Email: fengj@zju.edu.cn
Rights & Permissions [Opens in a new window]

Abstract

Excessive zinc (Zn) intake can lead to Zn toxicity, causing adverse effects in gastrointestinal system. To date, there remains no definitive consensus on the mechanisms by which Zn overload induces cell death and intestinal injury. This study was to assess the toxicity mechanism of Zn overload in intestine, with a particular concentrate on oxidative stress and energy metabolism. We first explore the effects of short- and long-term Zn imbalances on intestinal health in mice. We found that the Zn imbalances resulted in oxidative damage, and impaired ketoglutarate dehydrogenase (α-KGDH) activity, which collectively contributed to a detrimental impact on the integrity of the intestinal barrier in mice. We next determined the dynamics of oxidative stress and energy metabolism in Zn overload treatment IPEC-J2 cells. Excessive Zn activated reactive oxygen species (ROS) overproduction and the PKC-NOX oxidative stress pathway. Moreover, the increase of mitochondrial Zn2+ caused mitochondrial ROS accumulation and influenced the expressions of α-KGDH andisocitrate dehydrogenase (IDH), two pivotal rate-limiting enzymes in tricarboxylic acid (TCA) cycle. Zn overload also significantly inhibited the expressions of key nicotinamide adenine dinucleotide (NAD+) synthesis enzymes, namely NMNAT1 and NAMPT, leading to a notable decline of NAD+ and ATP. Furthermore, rescue experiments showed supplementation of NAD+ or boosting NAD+ synthesis, but not antioxidants addition, could rescue Zn toxicity. The collective findings suggest NAD+ reduction is the primary factor contributing to intestinal Zn toxicity, although ROS also plays a role. This indicates that the modulation of NAD+ synthesis may prove an effective strategy for the minimization or elimination of Zn toxicity.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Zhejiang University and Zhejiang University Press.
Figure 0

Figure 1. Effect of imbalanced dietary Zn on Zn transporter and tight junction protein. Experimental design of short-term and long-term Zn imbalance in mice (A). The expression levels of ZIP4 and MT in short-term Zn intervention (B–D). The expression levels of ZIP4 and MT in long-term Zn intervention (E–G). Results are given as mean ± SD (n = 3–4). the expression levels of ZO-1, occludin, and claudin-1 in short-term Zn intervention (H–K). the expression levels of ZO-1, occludin, and claudin-1 in long-term zn intervention (L–O). results are given as mean ± SD (n = 3–5). groups labeled without a common letter were significantly different (P < 0.05).

Figure 1

Figure 2. Effect of imbalanced dietary Zn on oxidative stress indicators. The levels of ROS (A–B), T-AOC (C), MDA (D), and NO (E) in short-term Zn intervention. The expression levels of ROS (F–G), T-AOC (H), MDA (I), and NO (J) in long-term Zn intervention. Results are given as mean ± SD (n = 4–8). groups labeled without a common letter were significantly different (P < 0.05).

Figure 2

Figure 3. Effect of imbalanced dietary Zn on oxidative stress related protein and α-KGDH. The expression levels of NOX2, nrf2, and p-nrf2 in short-term Zn intervention (A–D). The expression levels of NOX2, nrf2, and p-nrf2 in long-term Zn intervention (E–H). The activities of α-KGDH in short-term Zn intervention (I). The activities of α-KGDH in long-term Zn intervention (J). Results are given as mean ± SD (n = 3). groups labeled without a common letter were significantly different (P < 0.05).

Figure 3

Figure 4. Changes in cellular ROS levels and the expression levels of oxidative stress-related proteins following Zn treatment. Change of cellular ROS levels at various time intervals following Zn overload (A). Quantification of cellular ROS (B). Alterations in protein expression levels of cytoplasmic oxidative stress-related proteins at various time intervals following zn overload, including PKC, NOX2, NOX2, and DUOX2 (C–G). Alterations in protein expression levels of cytoplasmic antioxidant-related proteins at various time intervals following Zn overload, including nrf2, and p-nrf2 (H–J). Results are given as mean ± SD (n = 3–5). Groups labeled without a common letter were significantly different (P < 0.05).

Figure 4

Figure 5. Changes in status of mitochondrial Zn2+ and ROS following Zn treatment. Mitochondrial Zn2+ levels were determined through co-localization using mitotracker and fluozin-3 fluorescence (A). Quantification of mitochondrial Zn2+ (B). Flow cytometric analysis of mitochondrial ROS (C). Quantification of mitochondrial ROS (D); groups labeled without a common letter were significantly different (P < 0.05).

Figure 5

Figure 6. Changes in expression levels of expression levels of key enzymes in the tricarboxylic acid cycle as well as NAD+ and ATP following Zn treatment. Alterations in protein expression levels of cytoplasmic oxidative stress-related proteins at various time intervals following Zn overload, including OGDH, DLST, DLD, IDH1, and IDH2 (A–F). Results are given as mean ± SD (n = 3–5). Changes in NAD+ levels after Zn supplementation (G). Changes in ATP levels following Zn treatment (H). Results are given as mean ± SD (n = 8). groups labeled without a common letter were significantly different (P < 0.05).

Figure 6

Figure 7. The alleviating effect of NAD+ supplementation on zn overload-induced cell death. Effects of antioxidants DTT (A), vitamin e (B) and NAC (C) on Zn overload-induced cytotoxicity (n = 6). Flow cytometric analysis of intracellular Zn2+ (D). Quantification of intracellular Zn2+ levels (E) (n = 3). microscopy imaging (F). The influence of NAD+ supplementation on cell viability in high Zn concentrations, with NMN and NAD+ added at a concentration of 1 mm (G) (n = 6). flow cytometric analysis of intracellular Zn2+ (H). Quantification of intracellular Zn2+ levels (I) (n = 3). Results are given as mean ± SD; groups labeled without a common letter were significantly different (P < 0.05).

Figure 7

Figure 8. Changes in expression levels of NAD+-dependent sirtuin protein family, PARP-1 pathway proteins and NAD+ synthesis enzymes following Zn treatment. Alterations in protein expression levels of cytoplasmic oxidative stress-related proteins at various time intervals following zn overload, including SIRT1, SIRT3, SIRT4, and SIRT5 (A–E) (n = 3–5). Alterations in protein expression levels of PARP-1-related proteins at various time intervals following zn overload, including PARP-1, and AIF (F-H) (n = 3–5). (I) The alleviating impact of AIF inhibitor (BI-6C9, 5 μm) and PARP-1 inhibitor (AZD-9574, 5 μm) (n = 6). alterations in protein expression levels of NAD+ synthesis enzymes at various time intervals following zn overload, including NMNAT1, QPRT, and NAMPT (J-M) (n = 3–5). Results are given as mean ± SD. Groups labeled without a common letter were significantly different (P < 0.05).

Figure 8

Figure 9. The alleviating effect of boosting NAD+ synthesis on Zn overload-induced cell death. The alleviating impact of NAMPT activator NAT on cell viability (A) (n = 6), NAD+ concentration (B), ATP level (C) (n = 4), and the protein expression of NAMPT, NMNAT1, QPRT, SIRT1, SIRT3 as well as SIRT5 (D–J) (n = 3). The over expression efficiency of NMNAT1 and NAMPT (K–M) (n = 3). The alleviating impact of NMNAT1 and NAMPT overexpression (N) (n = 6). Statistical significance on the effects of NAT on protein expressions was determined using one-way ANOVA, followed by Duncan test. Results are given as mean ± SD; groups labeled without a common letter were significantly different (P < 0.05).

Supplementary material: File

Chen et al. supplementary material 1

Chen et al. supplementary material
Download Chen et al. supplementary material 1(File)
File 146.4 KB
Supplementary material: File

Chen et al. supplementary material 2

Chen et al. supplementary material
Download Chen et al. supplementary material 2(File)
File 445.5 KB